Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17016712 | 0.83 | TDP1 (0.47) | TDP1ALDH1A1TSHRHTTSMN1; SMN2 | |
| SCHEMBL13039993 | 0.83 | NPC1 (0.47) | TDP1ALDH1A1HTTSMN1; SMN2HPGD | |
| SCHEMBL855813 | 0.81 | HTT (0.44) | TDP1ALDH1A1TSHRHTTSMN1; SMN2 | |
| SCHEMBL13964076 | 0.81 | HTT (0.44) | TDP1ALDH1A1TSHRHTTSMN1; SMN2 | |
| SCHEMBL854763 | 0.81 | HTT (0.44) | TDP1ALDH1A1HTTSMN1; SMN2HPGD | |
| SCHEMBL4675294 | 0.81 | HTT (0.44) | TDP1ALDH1A1TSHRHTTSMN1; SMN2 | |
| Sumiki'S Acid SCHEMBL29706392 | 0.80 | TDP1 (1.00) | TDP1ALDH1A1TSHRHTTSMN1; SMN2 | |
| Sumiki'S Acid SCHEMBL50822 | 0.80 | TDP1 (1.00) | TDP1ALDH1A1TSHRHTTSMN1; SMN2 | |
| SCHEMBL6447185 | 0.80 | TDP1 (0.69) | TDP1ALDH1A1TSHRHTTSMN1; SMN2 | |
| SCHEMBL10067933 | 0.79 | SMN1; SMN2 (0.43) | TDP1ALDH1A1TSHRHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4464696-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | Konkuk University Industrial Cooperation Corp. (KR) | 2024-11-20 | — | — | EP | claimed |
| US-20230365742-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD OF PREPARING SAME COMPOUND, EPOXY COMPOSITE MATERIAL CONTAINING SAME COMPOUND, AND METHOD OF DEGRADING SAME COMPOSITE MATERIAL | KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP (KR) | 2023-11-16 | — | — | US | claimed |
| WO-2023136620-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | 건국대학교 산학협력단 | 2023-07-20 | — | — | WO | claimed |
| CN-106905146-B | Method for selective catalytic oxidation of biomass-based furan compound | 华南理工大学 | 2020-02-18 | — | — | CN | claimed |
| EP-4464696-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | Konkuk University Industrial Cooperation Corp. (KR) | 2024-11-20 | — | — | EP | disclosed |
| US-20230365742-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD OF PREPARING SAME COMPOUND, EPOXY COMPOSITE MATERIAL CONTAINING SAME COMPOUND, AND METHOD OF DEGRADING SAME COMPOSITE MATERIAL | KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP (KR) | 2023-11-16 | — | — | US | disclosed |
| WO-2023136620-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | 건국대학교 산학협력단 | 2023-07-20 | — | — | WO | disclosed |
| CN-112250721-B | Synthesis method and application of 1-methyl glucose | 郑州轻工业大学 | 2022-01-21 | — | — | CN | disclosed |
| US-11034979-B2 | Fungal production of FDCA | PURAC BIOCHEM B.V. (NL) | 2021-06-15 | — | — | US | disclosed |
| US-10993938-B2 | Lactam compound, preparation method and use thereof | OCEAN UNIVERSITY OF CHINA (CN) | 2021-05-04 | — | — | US | disclosed |
| CN-112250721-A | Synthesis method and application of 1-methyl glucose | 郑州轻工业大学 | 2021-01-22 | — | — | CN | disclosed |
| US-20210017556-A1 | PROCESS FOR OXIDISING A SUBSTRATE | BIOME BIOPLASTICS LIMITED (GB) | 2021-01-21 | — | — | US | disclosed |
| EP-2432760-A1 | BRIDGED SPIRO [2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010143116-A1 | FLUORINATED AMINOTRIAZOLE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2010-12-16 | — | — | WO | disclosed |
| WO-2010134014-A1 | BRIDGED SPIRO [2.4] HEPTANE DERIVATIVES AS ALX RECEPTOR AND/OR FPRL2 AGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2010-11-25 | — | — | WO | disclosed |
| WO-2010067102-A1 | DIAZASPIRO [5.5] UNDECANE DERIVATIVES AND RELATED COMPOUNDS AS MUSCARINIC-RECEPTOR ANTAGONISTS AND BETA-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF PULMONARY DISORDERS | ASTRAZENECA AB (SE) | 2010-06-17 | — | — | WO | disclosed |
| US-3992526-A | 5-Ethoxymethyl furfuryl ester of chrysanthemumic acid and its use as an insecticide | DAINIPPON JOCHUGIKU KABUSHIKI KAISHA (JA) | 1976-11-16 | — | — | US | disclosed |
| US-3982013-A | INSECTICIDES | DAINIPPON JOCHUGIKU KABUSHIKI KAISHA (JA) | 1976-09-21 | — | — | US | disclosed |
| US-3968238-A | INSECTICIDE | DAINIPPON JOCHUGIKU KABUSHIKI KAISHA (JA) | 1976-07-06 | — | — | US | disclosed |
| US-3932470-A | INSECTICIDES | DAINIPPON JOCHUGIKU KABUSHIKI KAISHA (JA) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10993938-B2 | Lactam compound, preparation method and use thereof | FURIN, PEPD, PIN1 | TDP1 3073/4885ALDH1A1 4014/4885TSHR 4676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.